A 10-Year Analysis of the Effects of Media Coverage of Regulatory Warnings on Antidepressant Use in The Netherlands and UK

• Juan Francisco Hernandez,

  Affiliation Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands

  ⨯
• Aukje K. Mantel-Teeuwisse,

  Affiliation Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands

  ⨯
• Ghislaine J. M. W. van Thiel,

  Affiliation Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands

  ⨯
• Svetlana V. Belitser,

  Affiliation Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands

  ⨯
• Jan Warmerdam,

  Affiliation IMS Health, Capelle aan den IJssel, The Netherlands

  ⨯
• Vincent de Valk,

  Affiliation Genees-en hulpmiddelen Informatie Project (GIP – Drug Information Project), Healthcare Insurance Board (CVZ), Diemen, The Netherlands

  ⨯
• Jan A. M. Raaijmakers,

  Affiliations Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands, GlaxoSmithKline, External Scientific Collaborations Europe, Zeist, The Netherlands

  ⨯
• Toine Pieters

  * E-mail: t.pieters@uu.nl

  Affiliations Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands, EMGO, VU Medical Centre, Amsterdam, The Netherlands

  ⨯